Julian Adams - Jul 27, 2022 Form 4 Insider Report for Gamida Cell Ltd. (GMDA)

Role
Chief Executive Officer, Director
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact
Stock symbol
GMDA
Transactions as of
Jul 27, 2022
Transactions value $
$0
Form type
4
Date filed
8/10/2022, 04:58 PM
Previous filing
Jan 3, 2022
Next filing
Nov 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMDA Ordinary Shares Award $0 +48.5K +63.69% $0.00 125K Jul 27, 2022 Direct F1, F2
transaction GMDA Ordinary Shares Award $0 +68.8K +55.19% $0.00 193K Jul 27, 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMDA Employee Share Option (Right to Buy) Award $0 +291K $0.00 291K Jul 27, 2022 Ordinary Shares 291K $2.93 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit ("RSU") award was approved by the Board of Directors of the Issuer on January 28, 2022, subject to shareholder approval. The Issuer's shareholders approved the grant at the annual general meeting of the shareholders on July 27, 2022.
F2 These shares represent an RSU award, which shall vest in three equal annual installments commencing on July 27, 2023. The vesting of the RSUs is subject to the Reporting Person's continuous service through such vesting date.
F3 These shares represent an RSU award, which shall vest in two equal annual installments commencing on December 31, 2022. The vesting of the RSUs is subject to the Reporting Person's continuous service through such vesting date.
F4 The option grant was approved by the Board of Directors of the Issuer on January 28, 2022, subject to shareholder approval. The Issuer's shareholders approved the grant at the annual general meeting of the shareholders on July 27, 2022.
F5 One fourth (1/4th) of the shares subject to the option award shall vest on July 27, 2023, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.